Health ministry sticks to price for leukemia drug

The Ministry of Health and Welfare (MOHW) said on January that it cannot reduce the price for Glivec, explaining that the price was officially announced by the HOHW minister after consultation of the drug evaluation committee and the health insurance policy deliberation committee under the current national health insurance law, instead of mutual consultation between the government and Novartis ...